← Back to Analyst Consensus 
NVO Hold
NOVO NORDISK A S
Current Price —
Implied Upside —
Analysts 35
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | BMO Capital | maintain | Market Perform → Market Perform | — | 53% |
| Sep 11, 2026 | Morgan Stanley | downgrade | Equal-Weight → Underweight | — | 54% |
| Mar 2, 2026 | Goldman Sachs | downgrade | Buy → Neutral | — | 54% |
| Feb 24, 2026 | JP Morgan | downgrade | Overweight → Neutral | $0 | 54% |
| Jan 9, 2026 | CICC | initiate | — → Outperform | $73.5 | 59% |
| Dec 8, 2025 | Argus Research | downgrade | Buy → Hold | $0 | 53% |
| Nov 28, 2025 | Goldman Sachs | maintain | Buy → Buy | $54 | 54% |
| Nov 25, 2025 | BMO Capital | maintain | Market Perform → Market Perform | $46 | 53% |
| Nov 24, 2025 | HSBC | downgrade | Buy → Hold | $0 | 53% |
| Oct 14, 2025 | BMO Capital | maintain | Market Perform → Market Perform | $55 | 53% |
| Oct 2, 2025 | HSBC | upgrade | Hold → Buy | $70 | 53% |
| Sep 29, 2025 | Morgan Stanley | downgrade | Equal-Weight → Underweight | $47 | 54% |
| Sep 17, 2025 | Berenberg | upgrade | Hold → Buy | $0 | 29% |
| Aug 19, 2025 | TD Cowen | maintain | Buy → Buy | $70 | 54% |
| Aug 5, 2025 | UBS | downgrade | Buy → Neutral | $0 | 54% |
| Jul 31, 2025 | HSBC | downgrade | Buy → Hold | $0 | 53% |
| Jul 30, 2025 | Barclays | downgrade | Overweight → Equal-Weight | $0 | 53% |
| Jun 18, 2025 | TD Cowen | reiterate | Buy → Buy | $105 | 54% |
| Apr 17, 2025 | BMO Capital | downgrade | Outperform → Market Perform | $64 | 53% |
| Jan 8, 2025 | UBS | upgrade | Sell → Buy | $0 | 54% |
| Dec 23, 2024 | BMO Capital | maintain | Outperform → Outperform | $105 | 53% |
| Nov 6, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $160 | 50% |
| Oct 22, 2024 | Citigroup | maintain | Buy → Buy | $10 | 54% |
| Oct 17, 2024 | BMO Capital | maintain | Outperform → Outperform | $156 | 53% |
| Oct 16, 2024 | Barclays | maintain | Overweight → Overweight | $10 | 53% |
| Oct 14, 2024 | BMO Capital | maintain | Market Perform → Market Perform | $10 | 53% |
| Oct 10, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $160 | 50% |
| Oct 10, 2024 | Jefferies | initiate | — → Buy | $15 | 52% |
| Sep 20, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $160 | 50% |
| Sep 16, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $160 | 50% |
| Sep 9, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $160 | 50% |
| Aug 19, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $160 | 50% |
| Aug 8, 2024 | BMO Capital | maintain | Outperform → Outperform | $160 | 53% |
| Aug 5, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $160 | 50% |
| Jul 1, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $160 | 50% |
| Jun 25, 2024 | BMO Capital | maintain | Outperform → Outperform | $163 | 53% |
| Jun 20, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $160 | 50% |
| Jun 17, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $160 | 50% |
| Jun 10, 2024 | Argus Research | maintain | Buy → Buy | $160 | 53% |
| Apr 18, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $160 | 50% |
| Apr 12, 2024 | BMO Capital | initiate | — → Outperform | $163 | 53% |
| Apr 5, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $160 | 50% |
| Apr 1, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $160 | 50% |
| Mar 20, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $160 | 50% |
| Mar 8, 2024 | Cantor Fitzgerald | maintain | Overweight → Overweight | $160 | 50% |
| Feb 20, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $140 | 50% |
| Feb 15, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $140 | 50% |
| Feb 14, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $140 | 50% |
| Feb 1, 2024 | Cantor Fitzgerald | maintain | Overweight → Overweight | $140 | 50% |
| Feb 1, 2024 | Argus Research | maintain | Buy → Buy | $125 | 53% |
Price Target Trend
Aug 4, 2026 Oct 26, 2026
EPS Estimates
0q —
+1q —
0y —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days